𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of amikacin in cystic fibrosis: A study of bronchial diffusion

✍ Scribed by E. Autret; S. Marchand; M. Breteau; B. Grenier


Publisher
Springer
Year
1986
Tongue
English
Weight
402 KB
Volume
31
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A comparison of bronchial drainage treat
✍ Janet Kluft; Leila Beker; Maria Castagnino; Judith Gaiser; Holly Chaney; Robert πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 442 KB πŸ‘ 2 views

We compared standard chest physical therapy and postural drainage (CPT/PD) with a new airway clearance therapy called high-frequency chest wall oscillation (HFCWO) in a group of stable cystic fibrosis (CF) patients. In this crossover trial, 29 CF patients (15 males, 14 females), aged 7-47 years that

Lack of inducible nitric oxide synthase
✍ Meng, Qing-Hai; Springall, David R.; Bishop, Anne E.; Morgan, Kevin; Evans, Tom πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 478 KB πŸ‘ 2 views

Cystic fibrosis (CF) is an inherited disorder associated with severe inflammation and repeated bacterial infection and colonization in the lung. Airway epithelium is involved in defence against bacteria, but this system may be defective in CF. Pro-inflammatory cytokines can stimulate the expression

Epidemiologic study of cystic fibrosis:
✍ Wayne J. Morgan; Steven M. Butler; Charles A. Johnson; Andrew A. Colin; Stacey C πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 341 KB πŸ‘ 2 views

## for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis Summary. Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk fact